US FDA Needs ‘More Streamlined’ REMS Enforcement Authority, Inspector General Says

 
• By Derrick Gingery
  
Concept image of Business Acronym IG as Inspector General written over road marking yellow paint line.
The HHS OIG also called for mandated opioid prescriber training through the REMS, but the FDA disagreed. • Source: Shutterstock
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Drug Safety

More from Pink Sheet